EOLS
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Head of Investor Relations
Evolus, Inc. (EOLS)Equibles does not estimate personal net worth.
Get an email with a short summary when Evolus, Inc. publishes a filing, an earnings call transcript or a press release.
Get EOLS alertsNareg Sagherian is recorded as Head of Investor Relations at Evolus, Inc. (EOLS). Nareg Sagherian has spoken on 10 earnings calls across 1 company, most recently for Evolus, Inc. on August 5, 2026. Evolus, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Evolus, Inc. includes David Moatazedi (CFO and Board Member), Albert G. White III (Board Member), Albert White III (Board Member) and 4 others.
“Thank you, Operator, and welcome to everyone joining us on today's call to review Everless' second quarter financial results.”
“Thank you, Operator, and welcome to everyone joining us on today's call to review Evelis' first quarter financial results.”
“Thank you, Operator, and welcome to everyone joining us on today's call to review Evalus' fourth quarter and full year 2025 financial results.”
“Thank you, operator, and welcome to everyone joining us on today's call to review Evolus' third quarter financial results.”
“Thank you, Operator, and welcome to everyone joining us on today's call to review Evalus' second quarter financial results.”
EOLS
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations